SCHEMBL4970451

SCHEMBL4970451

O=C(NCC(F)(F)F)NC(Cc1cccc(OS(=O)(=O)C(F)(F)F)c1)(c1ccccc1)c1ccc(F)c(C(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CETP P11597 16/20 0.45
MAPK14 Q16539 1/20 0.36
IDH2 P48735 1/20 0.35
KCNQ3 O43525 1/20 0.34
KCNQ2 O43526 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL758661 0.96 CETP (0.50) CETPMAPK14
SCHEMBL758660 0.96 CETP (0.50) CETPMAPK14
SCHEMBL760848 0.87 CETP (0.53) CETPKCNH2
SCHEMBL760849 0.87 CETP (0.53) CETPKCNH2
SCHEMBL13144045 0.84 CETP (0.56) CETPMAPK14KCNH2
SCHEMBL3068387 0.83 CETP (0.57) CETPKCNH2
SCHEMBL760961 0.83 CETP (0.57) CETPKCNH2
SCHEMBL760094 0.80 CETP (0.45) CETP
SCHEMBL760095 0.80 CETP (0.45) CETP
SCHEMBL760231 0.79 CETP (0.54) CETPKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1954668-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS Brystol-Myers Squibb Company (US) 2008-08-13 EP disclosed
WO-2007062308-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 WO disclosed